http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019059672-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dffbd04747d5d9b9492e7f2ac61db6 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
filingDate | 2015-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237c65b8e6a2e73e4ae1e6e977a005cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e68d82679ef5b96a82c4ecdf34727de9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b48cae77e8b4994d80c27496c79d05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb7647e34e110006b87f0eae8958b6e |
publicationDate | 2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019059672-A |
titleOfInvention | Therapeutic drugs such as treatment resistant depression |
abstract | The present invention provides a therapeutic agent and a therapeutic method for treatment-resistant depression, chronic depression or recurrent depression. The compound represented by the following formula (1) or a pharmaceutically acceptable salt thereof Provided is a method of treating refractory depression, chronic depression or recurrent depression comprising administering a therapeutically effective amount to a patient in need thereof, wherein Ar is a heteroaryl (the heteroaryl Represents C 1-3 alkyl, C 1-3 alkoxy or the like, V represents nitrogen or CH, W represents a single bond or C (O)-(wherein V represents In the case of nitrogen, W represents a single bond, and when V is CH, W represents a single bond or C (O)-), Y is phenyl (the phenyl is substituted with 1 to 3 halogens and (Optional), heteroaryl (the heteroaryl is substituted with 1 to 3 halogens) Which may also be) or 4-7 membered saturated heterocyclic ring (saturated heterocycle represents optionally substituted with 1 to 3 halogens). 【Selection chart】 None |
priorityDate | 2015-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.